Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing the Role of the NLRP3 Inflammasome in Driving Inflammation in Affected Joints of Patients With Intercritical Gout

NCT04125459 is registered in ClinicalTrials.gov with Attune Health Research, Inc. as lead sponsor.

NCT NCT04125459
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04125459 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing the Role of the NLRP3 Inflammasome in Driving Inflammation in Affected Joints of Patients With Intercritical Gout
Lead sponsor
Attune Health Research, Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
January 22, 2020
Completion date
October 3, 2024
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gout